Michele Mercuri Daiichi Sankyo Pharma Development Biography Publications Institution JoVE Articles Michele Mercuri has not added a biography. If you are Michele Mercuri and would like to personalize this page please email our Author Liaison for assistance. Publications A Prospective Evaluation of Edoxaban Compared to Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation: The EdoxabaN Vs. Warfarin in SubjectS UndeRgoing CardiovErsion of Atrial Fibrillation (ENSURE-AF) Study American Heart Journal. May, 2015 | Pubmed ID: 25965706 A Review of Antithrombotic Therapy and the Rationale and Design of the Randomized Edoxaban in Patients with Peripheral Artery Disease (ePAD) Trial Adding Edoxaban or Clopidogrel to Aspirin After Femoropopliteal Endovascular Intervention Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists. Apr, 2015 | Pubmed ID: 25809373 Association Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity, and Outcomes: an Analysis of Data from the Randomised, Double-blind ENGAGE AF-TIMI 48 Trial Lancet. Mar, 2015 | Pubmed ID: 25769361 Genetics and the Clinical Response to Warfarin and Edoxaban: Findings from the Randomised, Double-blind ENGAGE AF-TIMI 48 Trial Lancet. Mar, 2015 | Pubmed ID: 25769357 Edoxaban Vs. Warfarin in Vitamin K Antagonist Experienced and Naive Patients with Atrial Fibrillation† European Heart Journal. Feb, 2015 | Pubmed ID: 25687352 Transition of Patients from Blinded Study Drug to Open-label Anticoagulation: the ENGAGE AF-TIMI 48 Trial Journal of the American College of Cardiology. Aug, 2014 | Pubmed ID: 25104527 Cerebrovascular Events in 21 105 Patients with Atrial Fibrillation Randomized to Edoxaban Versus Warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 Stroke; a Journal of Cerebral Circulation. Aug, 2014 | Pubmed ID: 24947287 Left Atrial Structure and Function in Atrial Fibrillation: ENGAGE AF-TIMI 48 European Heart Journal. Jun, 2014 | Pubmed ID: 24302269 Edoxaban Versus Warfarin in Patients with Atrial Fibrillation The New England Journal of Medicine. Nov, 2013 | Pubmed ID: 24251359 Edoxaban Versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism The New England Journal of Medicine. Oct, 2013 | Pubmed ID: 23991658 Evaluation of the Novel Factor Xa Inhibitor Edoxaban Compared with Warfarin in Patients with Atrial Fibrillation: Design and Rationale for the Effective ANticoaGulation with Factor XA Next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction Study 48 (ENGAGE AF-TIMI 48) American Heart Journal. Oct, 2010 | Pubmed ID: 20934556 The Association of Myeloperoxidase Promoter Polymorphism with Carotid Atherosclerosis is Abolished in Patients with Type 2 Diabetes Clinical Biochemistry. May, 2008 | Pubmed ID: 18280811 The CD40/CD40 Ligand System in the Skin of Patients with Subacute Cutaneous Lupus Erythematosus The Journal of Rheumatology. Dec, 2007 | Pubmed ID: 18050371 Blood Leukocyte Count is a Risk Factor for Intima-media Thickening and Subclinical Carotid Atherosclerosis in Middle-aged Men Atherosclerosis. Oct, 2006 | Pubmed ID: 16378612 Coronary Artery Calcium Outperforms Carotid Artery Intima-media Thickness As a Noninvasive Index of Prevalent Coronary Artery Stenosis Arteriosclerosis, Thrombosis, and Vascular Biology. Aug, 2005 | Pubmed ID: 15947237 The Metabolic Syndrome and Risk of Major Coronary Events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) The American Journal of Cardiology. Jan, 2004 | Pubmed ID: 14715336 Differential Effects of Simvastatin and Atorvastatin on High-density Lipoprotein Cholesterol and Apolipoprotein A-I Are Consistent Across Hypercholesterolemic Patient Subgroups Clinical Cardiology. Nov, 2003 | Pubmed ID: 14640465 Carotid Arterial Structure in Patients with Documented Coronary Artery Disease and Disease-free Control Subjects Circulation. Mar, 2003 | Pubmed ID: 12615793 Radical-trapping Activity, Blood Pressure, and Carotid Enlargement in Women Hypertension. Feb, 2003 | Pubmed ID: 12574097 Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years' Follow-up by High-resolution Noninvasive Magnetic Resonance Imaging Circulation. Dec, 2002 | Pubmed ID: 12460866 Effects of Simvastatin on C-reactive Protein in Mixed Hyperlipidemic and Hypertriglyceridemic Patients The American Journal of Cardiology. Nov, 2002 | Pubmed ID: 12398959 Efficacy and Safety of Statin Therapy in Children with Familial Hypercholesterolemia: a Randomized, Double-blind, Placebo-controlled Trial with Simvastatin Circulation. Oct, 2002 | Pubmed ID: 12390953 Associations of Extracranial Carotid Atherosclerosis Progression with Coronary Status and Risk Factors in Patients with and Without Coronary Artery Disease Circulation. Oct, 2002 | Pubmed ID: 12379574 En Multi MRI protokoll för utvärdering och kvantifiering av djup ventrombos Venkatesh Mani1, Nadia Alie1, Sarayu Ramachandran1, Philip M. Robson1, Cecilia Besa1, Gregory Piazza2, Michele Mercuri3, Michael Grosso3, Bachir Taouli1, Samuel Z. Goldhaber2, Zahi A. Fayad1 1Department of Radiology, Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, 2Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 3Daiichi Sankyo Pharma Development Medicine
En Multi MRI protokoll för utvärdering och kvantifiering av djup ventrombos Venkatesh Mani1, Nadia Alie1, Sarayu Ramachandran1, Philip M. Robson1, Cecilia Besa1, Gregory Piazza2, Michele Mercuri3, Michael Grosso3, Bachir Taouli1, Samuel Z. Goldhaber2, Zahi A. Fayad1 1Department of Radiology, Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, 2Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 3Daiichi Sankyo Pharma Development Medicine
